Studies by Holland and colleagues have shown that CXCR4 signaling activation, as opposed to the quantitative surface expression of CXCR4, most strongly affects metastatic behavior of human breast cancer cells [10], and this is additionally suggested by database analysis from Fig 1A. The gene discussed is CXCR4; the disease is breast carcinoma.